1. Home
  2. PBBK vs ACXP Comparison

PBBK vs ACXP Comparison

Compare PBBK & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PB Bankshares Inc.

PBBK

PB Bankshares Inc.

HOLD

Current Price

$19.81

Market Cap

53.5M

Sector

Finance

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$2.95

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBBK
ACXP
Founded
1919
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
6.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PBBK
ACXP
Price
$19.81
$2.95
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$143.67
AVG Volume (30 Days)
10.8K
59.4K
Earning Date
02-25-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
53.39
N/A
EPS
0.98
N/A
Revenue
$13,918,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.21
N/A
Revenue Growth
17.20
N/A
52 Week Low
$14.23
$2.44
52 Week High
$22.92
$21.00

Technical Indicators

Market Signals
Indicator
PBBK
ACXP
Relative Strength Index (RSI) 43.68 39.63
Support Level $21.04 $2.44
Resistance Level $21.95 $3.54
Average True Range (ATR) 0.54 0.24
MACD -0.21 0.01
Stochastic Oscillator 9.43 43.19

Price Performance

Historical Comparison
PBBK
ACXP

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: